Global Protein Multiplex Assays 麻豆原创 Research Report 2025

Publication ID:

PB502255588

Publication Date:

February 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Protein Multiplex Assays was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Multiplex protein assays allow multiple targets quantification in a single sample, a bit like performing up to 40 different ELISAs in one go. Outsourcing Multiplex Protein Quantification projects to experts may work out more cost effective and time saving. It saves you the hassle of setting up a new technology in your lab, and you can rely on people with years of expertise in the technology to generate quality data on the very first run. Should you wish to set it up in your own lab, some technologies are easily adaptable if you have access to the equipment.
North American market for Protein Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Protein Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Protein Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Protein Multiplex Assays include Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Protein Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Multiplex Assays.
The Protein Multiplex Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Protein Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Protein Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Segment by Type
Planar Protein Assays
Bead-Based Protein Assays
Other Protein Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Protein Multiplex Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Protein Multiplex Assays 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Planar Protein Assays
1.2.3 Bead-Based Protein Assays
1.2.4 Other Protein Assays
1.3 麻豆原创 by Application
1.3.1 Global Protein Multiplex Assays 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Protein Multiplex Assays 麻豆原创 Perspective (2020-2031)
2.2 Global Protein Multiplex Assays Growth Trends by Region
2.2.1 Global Protein Multiplex Assays 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Protein Multiplex Assays Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Protein Multiplex Assays Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Protein Multiplex Assays 麻豆原创 Dynamics
2.3.1 Protein Multiplex Assays Industry Trends
2.3.2 Protein Multiplex Assays 麻豆原创 Drivers
2.3.3 Protein Multiplex Assays 麻豆原创 Challenges
2.3.4 Protein Multiplex Assays 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Protein Multiplex Assays Players by Revenue
3.1.1 Global Top Protein Multiplex Assays Players by Revenue (2020-2025)
3.1.2 Global Protein Multiplex Assays Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Protein Multiplex Assays 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Protein Multiplex Assays Revenue
3.4 Global Protein Multiplex Assays 麻豆原创 Concentration Ratio
3.4.1 Global Protein Multiplex Assays 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein Multiplex Assays Revenue in 2024
3.5 Global Key Players of Protein Multiplex Assays Head office and Area Served
3.6 Global Key Players of Protein Multiplex Assays, Product and Application
3.7 Global Key Players of Protein Multiplex Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Multiplex Assays Breakdown Data by Type
4.1 Global Protein Multiplex Assays Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Protein Multiplex Assays Forecasted 麻豆原创 Size by Type (2026-2031)
5 Protein Multiplex Assays Breakdown Data by Application
5.1 Global Protein Multiplex Assays Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Protein Multiplex Assays Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Protein Multiplex Assays 麻豆原创 Size (2020-2031)
6.2 North America Protein Multiplex Assays 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Protein Multiplex Assays 麻豆原创 Size by Country (2020-2025)
6.4 North America Protein Multiplex Assays 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Protein Multiplex Assays 麻豆原创 Size (2020-2031)
7.2 Europe Protein Multiplex Assays 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Protein Multiplex Assays 麻豆原创 Size by Country (2020-2025)
7.4 Europe Protein Multiplex Assays 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Protein Multiplex Assays 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Protein Multiplex Assays 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Protein Multiplex Assays 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Protein Multiplex Assays 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Protein Multiplex Assays 麻豆原创 Size (2020-2031)
9.2 Latin America Protein Multiplex Assays 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Protein Multiplex Assays 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Protein Multiplex Assays 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Protein Multiplex Assays 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Protein Multiplex Assays 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Protein Multiplex Assays 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Protein Multiplex Assays 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luminex Corporation
11.1.1 Luminex Corporation Company Details
11.1.2 Luminex Corporation Business Overview
11.1.3 Luminex Corporation Protein Multiplex Assays Introduction
11.1.4 Luminex Corporation Revenue in Protein Multiplex Assays Business (2020-2025)
11.1.5 Luminex Corporation Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Protein Multiplex Assays Introduction
11.2.4 Thermo Fisher Scientific Revenue in Protein Multiplex Assays Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Protein Multiplex Assays Introduction
11.3.4 Bio-Rad Laboratories Revenue in Protein Multiplex Assays Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Protein Multiplex Assays Introduction
11.4.4 Qiagen Revenue in Protein Multiplex Assays Business (2020-2025)
11.4.5 Qiagen Recent Development
11.5 Abcam
11.5.1 Abcam Company Details
11.5.2 Abcam Business Overview
11.5.3 Abcam Protein Multiplex Assays Introduction
11.5.4 Abcam Revenue in Protein Multiplex Assays Business (2020-2025)
11.5.5 Abcam Recent Development
11.6 Becton
11.6.1 Becton Company Details
11.6.2 Becton Business Overview
11.6.3 Becton Protein Multiplex Assays Introduction
11.6.4 Becton Revenue in Protein Multiplex Assays Business (2020-2025)
11.6.5 Becton Recent Development
11.7 Dickinson and Company
11.7.1 Dickinson and Company Company Details
11.7.2 Dickinson and Company Business Overview
11.7.3 Dickinson and Company Protein Multiplex Assays Introduction
11.7.4 Dickinson and Company Revenue in Protein Multiplex Assays Business (2020-2025)
11.7.5 Dickinson and Company Recent Development
11.8 Merck KGaA
11.8.1 Merck KGaA Company Details
11.8.2 Merck KGaA Business Overview
11.8.3 Merck KGaA Protein Multiplex Assays Introduction
11.8.4 Merck KGaA Revenue in Protein Multiplex Assays Business (2020-2025)
11.8.5 Merck KGaA Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Protein Multiplex Assays Introduction
11.9.4 Agilent Technologies Revenue in Protein Multiplex Assays Business (2020-2025)
11.9.5 Agilent Technologies Recent Development
11.10 Bio-Techne
11.10.1 Bio-Techne Company Details
11.10.2 Bio-Techne Business Overview
11.10.3 Bio-Techne Protein Multiplex Assays Introduction
11.10.4 Bio-Techne Revenue in Protein Multiplex Assays Business (2020-2025)
11.10.5 Bio-Techne Recent Development
11.11 Shimadzu Biotech
11.11.1 Shimadzu Biotech Company Details
11.11.2 Shimadzu Biotech Business Overview
11.11.3 Shimadzu Biotech Protein Multiplex Assays Introduction
11.11.4 Shimadzu Biotech Revenue in Protein Multiplex Assays Business (2020-2025)
11.11.5 Shimadzu Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.